Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Repetitive transcranial magnetic stimulation for treatment-resistant depression: OHTAC recommendation. Toronto: Health Quality Ontario (HQO). 2016 Authors' conclusions OHTAC recognizes that electroconvulsive therapy (ECT) is the most effective treatment for non-psychotic, treatment-resistant depression. OHTAC therefore recommends that repetitive transcranial magnetic stimulation be publicly funded for patients with nonpsychotic, treatment-resistant depression only when ECT is not an option.
Health Quality Ontario conducted a review to determine the clinical effectiveness of rTMS compared to either electroconvulsive therapy or sham treatment. In addition, Health Quality Ontario worked with the Programs for Assessment of Technology in Health (PATH) Research Institute to evaluate cost-effectiveness and one-year budgetary impact of the technology. Indexing Status Subject indexing assigned by CRD MeSH Depression; Depressive Disorder, Treatment-Resistant; Humans; Transcranial Magnetic Stimulation; Treatment Outcome Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5 Email: EDSinfo@hqontario.ca AccessionNumber 32016000560 Date abstract record published 22/03/2016 |